ABOUT SCIENSYNC
Science Without Borders.
Healthcare Without Limits.
Clinically validated healthcare platforms advancing regenerative aesthetics, microbiome science, and reproductive innovation.
10+
Years • Est. 2016
4,630+
Physicians Reached
+414%
Revenue Growth
BUILT ON GLOBAL STANDARDS. DELIVERED WITH INTEGRITY.





ABOUT SCIENSYNC
Advancing Healthcare Through Global Scientific Integration
ScienSync International Inc. is a bi-continental medical platform governed from Canada and deployed across the Middle East and Europe — bridging pharmaceutical-grade science with clinical practice worldwide.
The platform integrates regenerative aesthetics, microbiome science, and reproductive innovation into a unified, clinically validated ecosystem serving Canada, KSA, Bahrain, and Egypt.
Scientific Governance
Canada-governed scientific council overseeing formulations
Clinical Validation
Robust patient safety registries & strict RCT validations
Global Manufacturing
EU GMP accredited facilities ensuring high regulatory standards
Physician Partnership
Direct support systems and hand-in-hand medical education

One Platform. Multiple Disciplines.
Global Impact.
Identity
The Principles Behind Every Innovation
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Vision
Platform Leadership in Global Precision Healthcare
To become a globally recognized, bi-continental healthcare platform that bridges advanced scientific innovation with clinical excellence — delivering pharmaceutical-grade solutions across Europe, Canada, and the Middle East. To redefine how regenerative medicine, microbiome science, and reproductive health are integrated into real-world clinical practice.
MISSION
Translating Science into Measurable Patient Impact
ScienSync is dedicated to harnessing the power of science in harmony with human well-being — transforming clinically validated innovations into accessible, high-impact healthcare solutions. Through global regulatory governance, EU GMP manufacturing, and physician-led execution, ScienSync delivers immediate, tangible outcomes in dermatology, microbiome therapy, and reproductive medicine.
Scientific Integrity
Every claim is grounded in published research, clinical validation, and evidence-based medicine. Science governs every decision — never marketing.
Patient Safety
Physician-led protocols and safety-first design ensure every product meets the highest standards of clinical application and patient protection.
Regulatory Discipline
Full compliance with Health Canada, EU GMP, and SFDA frameworks. No shortcuts. Every product meets global regulatory standards before reaching the market.
Physician Partnership
Built with doctors, not for them. Continuous clinical feedback directly shapes product development, protocols, and platform strategy.
Physician Partnership
Built with doctors, not for them. Continuous clinical feedback directly shapes product development, protocols, and platform strategy.
Physician Partnership
Built with doctors, not for them. Continuous clinical feedback directly shapes product development, protocols, and platform strategy.
GLOBAL SCIENTIFIC NETWORK
A Global Scientific Ecosystem
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Strategic Capabilities
Built for Global Scientific Ecosystem
Multi-Jurisdiction Regulatory
CA · KSA · BH · EG
Full regulatory infrastructure across Canada, Saudi Arabia, Bahrain, and Egypt — including SFDA registration, Health Canada licensing, and import compliance.
EU GMP Manufacturing
ISO 22716 + 13485
All products manufactured under EU GMP conditions. ISO 22716 and 13485 certified. Cold-chain validated supply chain from European facilities to MENA point of care.
Clinical Medical Education
40+ Workshops Canada & KSA
Hands-on injection workshops, KOL masterclasses programs, and CME-accredited education events. 1,200+ physicians trained with 92% feedback score.
Digital Commercial Excellence
Omnichannel Data-Driven
E-detailing platform, CRM intelligence system, 98% HCP reach rate, 3+ field efficiency. Seamless omnichannel service across digital and physical touchpoints.
Digital Commercial Excellence
Omnichannel Data-Driven
E-detailing platform, CRM intelligence system, 98% HCP reach rate, 3+ field efficiency. Seamless omnichannel service across digital and physical touchpoints.
Digital Commercial Excellence
Omnichannel Data-Driven
E-detailing platform, CRM intelligence system, 98% HCP reach rate, 3+ field efficiency. Seamless omnichannel service across digital and physical touchpoints.
— Institutional Journey · 2016 — Present
European Science · Canadian Governance
Middle East Execution
2016
Foundation in Cairo
- Company established in Egypt
- Initial dermatology portfolio
- Foundation team assembled
2019
Canadian Headquarters
- trategic relocation to Canada
- North American regulatory base
- Health Canada framework initiated
2020
GCC Market Expansion
- Expansion across Saudi Arabia & GCC
- SFDA regulatory engagement
- Regional commercial deployment
2024
Neuvage Platform Launch
- SFDA-registered injectable platform
- European manufacturing engaged
- Full NEUVAGE system commercialised
What Our Doctors Say